Press Release September 13, 2022

Legend Capital Invests in Nuwacell Biotechnologies

The Life Sciences team advised Legend Capital on its leading investment in Nuwacell Biotechnologies’ Series A financing round. 

Legend Capital is a private equity fund manager and a member of Legend Holdings.

Nuwacell Biotechnologies is a high-tech enterprise focusing on human induced pluripotent stem cells research and clinical transformation.

The Goodwin team was led by Can Cui and included Yingying Cai and Megan Gustafson.

For more details, read the article in EqualOcean.